Works matching AU Kawashima, Yosuke


Results: 22
    1

    Association Between Skin Reaction and Clinical Benefit in Patients Treated with Anti‐Programmed Cell Death 1 Monotherapy for Advanced Non‐Small Cell Lung Cancer.

    Published in:
    Oncologist, 2020, v. 25, n. 3, p. e536, doi. 10.1634/theoncologist.2019-0550
    By:
    • Aso, Mari;
    • Toi, Yukihiro;
    • Sugisaka, Jun;
    • Aiba, Tomoiki;
    • Kawana, Sachiko;
    • Saito, Ryohei;
    • Ogasawara, Takahiro;
    • Tsurumi, Kyoji;
    • Ono, Kana;
    • Shimizu, Hisashi;
    • Domeki, Yutaka;
    • Terayama, Keisuke;
    • Kawashima, Yosuke;
    • Nakamura, Atsushi;
    • Yamanda, Shinsuke;
    • Kimura, Yuichiro;
    • Honda, Yoshihiro;
    • Sugawara, Shunichi
    Publication type:
    Article
    2

    Association of Immune‐Related Adverse Events with Clinical Benefit in Patients with Advanced Non‐Small‐Cell Lung Cancer Treated with Nivolumab.

    Published in:
    Oncologist, 2018, v. 23, n. 11, p. 1358, doi. 10.1634/theoncologist.2017-0384
    By:
    • Toi, Yukihiro;
    • Sugawara, Shunichi;
    • Kawashima, Yosuke;
    • Aiba, Tomoiki;
    • Kawana, Sachiko;
    • Saito, Ryohei;
    • Tsurumi, Kyoji;
    • Suzuki, Kana;
    • Shimizu, Hisashi;
    • Sugisaka, Jun;
    • Ono, Hirotaka;
    • Domeki, Yutaka;
    • Terayama, Keisuke;
    • Nakamura, Atsushi;
    • Yamanda, Shinsuke;
    • Kimura, Yuichiro;
    • Honda, Yoshihiro
    Publication type:
    Article
    3
    4

    Subsequent treatment for locally advanced non-small-cell lung cancer that progressed after definitive chemoradiotherapy and consolidation therapy with durvalumab: a multicenter retrospective analysis (TOPGAN 2021-02).

    Published in:
    Cancer Chemotherapy & Pharmacology, 2023, v. 92, n. 1, p. 29, doi. 10.1007/s00280-023-04547-2
    By:
    • Hasegawa, Tsukasa;
    • Ariyasu, Ryo;
    • Tanaka, Hisashi;
    • Saito, Ryota;
    • Kawashima, Yosuke;
    • Horiike, Atsushi;
    • Sakatani, Toshio;
    • Tozuka, Takehiro;
    • Shiihara, Jun;
    • Saiki, Masafumi;
    • Tambo, Yuichi;
    • Sonoda, Tomoaki;
    • Miyazaki, Akito;
    • Uematsu, Shinya;
    • Tsuchiya-Kawano, Yuko;
    • Yanagitani, Noriko;
    • Nishino, Makoto
    Publication type:
    Article
    5

    Association of immune‐related pneumonitis with clinical benefit of anti‐programmed cell death‐1 monotherapy in advanced non‐small cell lung cancer.

    Published in:
    Cancer Medicine, 2021, v. 10, n. 14, p. 4796, doi. 10.1002/cam4.4045
    By:
    • Ono, Kana;
    • Ono, Hirotaka;
    • Toi, Yukihiro;
    • Sugisaka, Jun;
    • Aso, Mari;
    • Saito, Ryohei;
    • Kawana, Sachiko;
    • Aiba, Tomoiki;
    • Odaka, Tetsuo;
    • Matsuda, Suguru;
    • Saito, Shin;
    • Narumi, Akane;
    • Ogasawara, Takahiro;
    • Shimizu, Hisashi;
    • Domeki, Yutaka;
    • Terayama, Keisuke;
    • Kawashima, Yosuke;
    • Nakamura, Atsushi;
    • Yamanda, Shinsuke;
    • Kimura, Yuichiro
    Publication type:
    Article
    6

    Clinical evaluation of a non-purified direct molecular assay for the detection of Clostridioides difficile toxin genes in stool specimens.

    Published in:
    PLoS ONE, 2020, v. 15, n. 6, p. 1, doi. 10.1371/journal.pone.0234119
    By:
    • Hara, Toshinori;
    • Suzuki, Hiromichi;
    • Oyanagi, Tadatomo;
    • Koyanagi, Norito;
    • Ushiki, Akihito;
    • Kawabata, Naoki;
    • Goto, Miki;
    • Hida, Yukio;
    • Yaguchi, Yuji;
    • Tamai, Kiyoko;
    • Notake, Shigeyuki;
    • Kawashima, Yosuke;
    • Sugiyama, Akio;
    • Uemura, Keiichi;
    • Kashiyama, Seiya;
    • Nanmoku, Toru;
    • Suzuki, Satoshi;
    • Yamazaki, Hiroshi;
    • Kimura, Hideki;
    • Kunishima, Hiroyuki
    Publication type:
    Article
    7
    8
    9
    10

    Clinical efficacy of amrubicin in patients with small cell lung cancer relapse after first‐line treatment including immune checkpoint inhibitors: A retrospective multicenter study (TOPGAN 2021‐01).

    Published in:
    Thoracic Cancer, 2023, v. 14, n. 2, p. 168, doi. 10.1111/1759-7714.14729
    By:
    • Uematsu, Shinya;
    • Kitazono, Satoru;
    • Tanaka, Hisashi;
    • Saito, Ryota;
    • Kawashima, Yosuke;
    • Ohyanagi, Fumiyoshi;
    • Tozuka, Takehiro;
    • Ryosuke, Tsugitomi;
    • Sakatani, Toshio;
    • Horiike, Atsushi;
    • Yoshizawa, Takahiro;
    • Saiki, Masafumi;
    • Tambo, Yuichi;
    • Koyama, Junji;
    • Kanazu, Masaki;
    • Kudo, Keita;
    • Tsuchiya‐Kawano, Yuko;
    • Yanagitani, Noriko;
    • Nishio, Makoto
    Publication type:
    Article
    11
    12

    Clinical efficacy of dacomitinib in rechallenge setting for patients with epidermal growth factor receptor mutant non–small cell lung cancer: A multicenter retrospective analysis (TOPGAN2020‐02).

    Published in:
    Thoracic Cancer, 2022, v. 13, n. 10, p. 1471, doi. 10.1111/1759-7714.14415
    By:
    • Tanaka, Hisashi;
    • Sakamoto, Hiroaki;
    • Akita, Takahiro;
    • Ohyanagi, Fumiyoshi;
    • Kawashima, Yosuke;
    • Tambo, Yuichi;
    • Tanimoto, Azusa;
    • Horiike, Atsushi;
    • Miyauchi, Eisaku;
    • Tsuchiya‐Kawano, Yuko;
    • Yanagitani, Noriko;
    • Nishio, Makoto
    Publication type:
    Article
    13

    Clinical impact of hypomagnesemia induced by necitumumab plus cisplatin and gemcitabine treatment in patients with advanced lung squamous cell carcinoma: a subanalysis of the NINJA study.

    Published in:
    Therapeutic Advances in Medical Oncology, 2025, p. 1, doi. 10.1177/17588359251318850
    By:
    • Tanzawa, Shigeru;
    • Yoshioka, Hiroshige;
    • Misumi, Toshihiro;
    • Miyauchi, Eisaku;
    • Ninomiya, Kiichiro;
    • Murata, Yasunori;
    • Takeshita, Masafumi;
    • Kinoshita, Fumihiko;
    • Fujishita, Takatoshi;
    • Sugawara, Shunichi;
    • Kawashima, Yosuke;
    • Hashimoto, Kazuki;
    • Mori, Masahide;
    • Miyanaga, Akihiko;
    • Hayashi, Anna;
    • Tanaka, Hisashi;
    • Honda, Ryoichi;
    • Nojiri, Masafumi;
    • Sato, Yuki;
    • Hata, Akito
    Publication type:
    Article
    14
    15

    Randomized phase II trial of carboplatin + nab-paclitaxel versus cisplatin + gemcitabine for chemotherapy-naïve squamous cell carcinoma: North Japan lung cancer study group 1302.

    Published in:
    International Journal of Clinical Oncology, 2021, v. 26, n. 3, p. 515, doi. 10.1007/s10147-020-01828-1
    By:
    • Kawashima, Yosuke;
    • Harada, Toshiyuki;
    • Fujita, Yuka;
    • Nakagawa, Taku;
    • Watanabe, Kana;
    • Morikawa, Naoto;
    • Takamura, Kei;
    • Kanazawa, Kenya;
    • Kuda, Tomoya;
    • Usui, Kazuhiro;
    • Sekine, Akimasa;
    • Inoue, Akira;
    • Sugawara, Shunichi
    Publication type:
    Article
    16
    17

    Prospective Multi-Institutional Observational Study of Retreatment with Anti-PD-1/PD-L1 Antibodies in Patients with Non-Small Cell Lung Cancer Previously Treated with Anti-PD-1/PD-L1 Plus Chemotherapy: NJLCG (North Japan Lung Cancer Group) Trial 1901.

    Published in:
    Cancers, 2025, v. 17, n. 9, p. 1551, doi. 10.3390/cancers17091551
    By:
    • Saito, Shin;
    • Kawashima, Yosuke;
    • Tanaka, Hisashi;
    • Yoshimura, Naruo;
    • Tsukita, Yoko;
    • Saito, Ryota;
    • Nakagawa, Taku;
    • Inomata, Minehiko;
    • Nagashima, Hiromi;
    • Sugawara, Shunichi
    Publication type:
    Article
    18

    Durvalumab after chemoradiotherapy in non‐small cell lung cancer with EGFR mutation: A real‐world study (HOT2101).

    Published in:
    Cancer Science, 2024, v. 115, n. 4, p. 1273, doi. 10.1111/cas.16094
    By:
    • Tsuji, Kosuke;
    • Mizugaki, Hidenori;
    • Yokoo, Keiki;
    • Kobayashi, Maki;
    • Kawashima, Yosuke;
    • Kimura, Nozomu;
    • Yokouchi, Hiroshi;
    • Kikuchi, Hajime;
    • Sumi, Toshiyuki;
    • Kawai, Yasutaka;
    • Kobashi, Kenta;
    • Morita, Ryo;
    • Ito, Kenichiro;
    • Kitamura, Yasuo;
    • Minemura, Hiroyuki;
    • Nakamura, Keiichi;
    • Aso, Mari;
    • Honjo, Osamu;
    • Tanaka, Hisashi;
    • Takashina, Taichi
    Publication type:
    Article
    19

    A retrospective study of the efficacy of combined EGFR-TKI plus VEGF inhibitor/cytotoxic therapy vs. EGFR-TKI monotherapy for PD-L1-positive EGFR-mutant non-small cell lung cancer: North Japan Lung Cancer Study Group 2202.

    Published in:
    Oncology Letters, 2023, v. 26, n. 2, p. 1, doi. 10.3892/ol.2023.13920
    By:
    • MINEHIKO INOMATA;
    • YOSUKE KAWASHIMA;
    • RYOTA SAITO;
    • DAISUKE MORINAGA;
    • HITOMI NOGAWA;
    • MASAMICHI SATO;
    • YOHEI SUZUK;
    • SATORU YANAGISAWA;
    • TAKASHI KIKUCHI;
    • DAISUKE JINGU;
    • NARUO YOSHIMURA;
    • TOSHIYUKI HARADA;
    • EISAKU MIYAUCHI
    Publication type:
    Article
    20
    21

    Successful Application of Tocilizumab in a Patient With Neoadjuvant Immunochemotherapy‐Induced Cytokine Release Syndrome.

    Published in:
    Cancer Reports, 2024, v. 7, n. 7, p. 1, doi. 10.1002/cnr2.2145
    By:
    • Minami, Soichiro;
    • Kawashima, Yosuke;
    • Munakata, Yasuhiko;
    • Matsuno, Masahiro;
    • Hara, Shuichiro;
    • Yamazaki, Yusuke;
    • Doman, Tsuyoshi;
    • Saito, Shin;
    • Odaka, Tetsuo;
    • Ogasawara, Takahiro;
    • Shimizu, Hisashi;
    • Sugisaka, Jun;
    • Aiba, Tomoiki;
    • Toi, Yukihiro;
    • Yamanda, Shinsuke;
    • Kimura, Yuichiro;
    • Sugawara, Shunichi
    Publication type:
    Article
    22

    Successful application of lorlatinib in a 23‐year‐old patient with anaplastic lymphoma kinase (ALK)‐positive lung cancer and multiple brain metastases.

    Published in:
    Cancer Reports, 2024, v. 7, n. 2, p. 1, doi. 10.1002/cnr2.1981
    By:
    • Murakami, Yosuke;
    • Kawashima, Yosuke;
    • Chiba, Shinji;
    • Hara, Shuichiro;
    • Yamazaki, Yusuke;
    • Doman, Tsuyoshi;
    • Saito, Shin;
    • Odaka, Tetsuo;
    • Ogasawara, Takahiro;
    • Shimizu, Hisashi;
    • Sugisaka, Jun;
    • Aiba, Tomoiki;
    • Toi, Yukihiro;
    • Yamanda, Shinsuke;
    • Kimura, Yuichiro;
    • Sugawara, Shunichi
    Publication type:
    Article